CLINICAL_TRIALS ClinicalTrials.gov record update

Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04517175
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:03.569556+00:00
Published At: 2020-08-18T00:00:00+00:00
Record Updated At: 2020-08-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Myelodysplastic Syndromes", "Acute Myeloid Leukemia", "Myelodysplastic Syndrome/Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-08-18"
protocolSection.identificationModule.nctId: "NCT04517175"
protocolSection.identificationModule.officialTitle: "Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.